Regulation of Phosphate Homeostasis
Dietary intake of Pi is absorbed in the small intestine, reabsorbed in the kidney and deposited in the bone. Several factors affect phosphate homeostasis in the body. Major phosphaturic factors, PTH and FGF23 strongly induce Pi excretion into the urine. The 1,25-dihydroxyvitamin D 3 is a major inducer of intestinal Pi absorption. Dietary Pi also regulates intestinal and renal Pi (re)absorption. A low-Pi diet induces intestinal and renal Pi transport, whereas a high-Pi diet suppresses intestinal and renal Pi transport. These factors control the Pi balance in the body (1-5).
Intestinal and Renal Phosphate (Re)Absorption via NaPi Transporters
Phosphate (re)absorption is mediated by NaPi transporters. The NaPi transporter SLC34 is mainly responsible for Pi homeostasis in the body (1, 4) . Three members of the SLC34 transporter family (SLC34A1-3) have been identified. SLC34A1 (NaPi-IIa) is predominantly expressed in the kidney, mediating 70% to 80% of Pi reabsorption in mice. Another member of this family, SLC34A3 (NaPi-IIc), is also expressed in the kidney. SLC34A2 (NaPi-IIb) is expressed in the small intestine and the lung, liver, salivary gland, mammary gland, and testis, as well as several other tissues.
Renal NaPi-IIa and NaPi-IIc, and intestinal NaPiIIb expression are stimulated in response to a low-Pi diet, and suppressed by a high-Pi diet. PTH and FGF23 strongly suppress renal NaPi-IIa and NaPi-IIc transporter expression. The 1,25-dihydroxyvitamin D 3 stimulates intestinal NaPi-IIb expression.
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Gene Knockout of NaPi Transporters
Renal Pi reabsorption is markedly reduced in NaPi-IIa knockout (KO) (Npt2a
) mice, resulting in hyperphosphaturia. Serum 1,25-dihydroxyvitamin D3 concentrations and serum and urine Ca 21 concentrations are significantly increased in Npt2a 2/2 mice (1, 4). In mice, NaPi-IIa has a major role in Pi reabsorbption.
Although Pi homeostasis remains normal in NaPi-IIc KO (Npt2c 2/2 ) mice hypercalciuria and higher levels of serum 1,25-dihydroxyvitamin D3 concentrations are observed. NaPi-IIc has a minor role in Pi reabsorption in mice (1, 4, 6) .
Neither Npt2a 2/2 nor Npt2c 2/2 mice exhibit bone abnormalities such as rickets/osteomalacia (6, 7) .
Homozygous NaPi-IIb KO mice display embryonic lethality. Based on several studies of heterozygous NaPiIIb KO (Npt2b 1/2 ) mice and conditional KO mice (3, 5, 8) , NaPi-IIb is the most important transcellular NaPi transporter.
Phosphate Transporter and Related Disease
Mutation of human NaPi-IIa causes autosomal recessive Fanconi syndrome with hypophosphatemic rickets (9) . This mutation of NaPi-IIa is a homozygous in-frame duplication. Functional studies indicate a complete loss of function of mutant NaPi-IIa. Accumulation of mutant NaPi-IIa protein in the cells may have toxic effects leading to Fanconi syndrome.
Mutation of NaPI-IIc causes autosomal recessive disorder hereditary hypophosphatemic rickets with hypercalciuria (HHRH) (4, 10) . Clinical studies suggest that HHRH is a primary renal Pi wasting disorder, resulting in increased serum 1,25-dihydroxyvitamin D3 concentrations with associated intestinal Ca 21 hyperabsorption, hypercalciuria, and rickets/osteomalacia. Functional studies suggest that homozygous or compound heterozygous mutation of NaPi-IIc significantly decreases NaPi transport activity in Xenopus oocytes and opossum kidney cells (11) . A recent report suggested that mutations in NaPi-IIc are associated with kidney stones and nephrocalcinosis (12) . NaPi-2c knockout (Npt2c KO) mice exhibit hypercalciuria and higher levels of serum 1,25-dihydroxyvitamin D3 concentrations, but not hypophosphatemia, rickets or nephrocalcinosis (6) . Furthermore, only NaPi-IIa/NaPi-IIc double-KO mice exhibit a physiology similar to that of patients with HHRH (13) . NaPi-IIc has more important roles in Pi reabsorption in humans than in mice. Both NaPi-IIa and NaPi-IIc are important NaPi transporters in humans; however, there are several differences between humans and rodents. Further studies are needed to clarify their precise role in human kidney function.
Mutation of NaPi-IIb causes pulmonary alveolar microlithiasis (PAM) (14) . The deposition of Ca/Pi microliths throughout the lungs is observed in PAM patients. NaPi-IIb is specifically expressed in type II alveolar cells, and NaPi-IIb mutations abolish the normal gene function.
Future Studies
The review is summarized in Fig. 1 and Table 1 . Control of Pi balance is tightly regulated in the body via Pi homeostasis-regulating factors and transporters. Several factors, such as the basolatheral/excretion type of Pi transporter, remain unidentified. In addi- Fig. 1 . Regulation of phosphate homeostasis. Pi homeostasis is maintained by the coordinated function of the renal and intestinal sodium-dependent phosphate transporters (NaPi) with dietary Pi, parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3, and fibroblast growth factor 23 (FGF23). Pi homeostasis in the body is mainly controlled by the type II NaPi transporter/SLC34 family. Three members of the SLC34 family have been identified to date: SLC34A1 and SCL34A3, which are predominantly expressed in the kidney, and SLC34A2, which is expressed in the small intestine. 
